Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 20


Implementation of cervical cancer prevention services for HIV-infected women in Zambia: measuring program effectiveness.

Parham GP, Mwanahamuntu MH, Sahasrabuddhe VV, Westfall AO, King KE, Chibwesha C, Pfaendler KS, Mkumba G, Mudenda V, Kapambwe S, Vermund SH, Hicks ML, Stringer JS, Chi BH.

HIV Ther. 2010;4(6):703-722.


Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008.

Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM.

Int J Cancer. 2010 Dec 15;127(12):2893-917. doi: 10.1002/ijc.25516.


Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial.

Denny L, Kuhn L, Hu CC, Tsai WY, Wright TC Jr.

J Natl Cancer Inst. 2010 Oct 20;102(20):1557-67. doi: 10.1093/jnci/djq342. Epub 2010 Sep 30.


Expansion of cancer care and control in countries of low and middle income: a call to action.

Farmer P, Frenk J, Knaul FM, Shulman LN, Alleyne G, Armstrong L, Atun R, Blayney D, Chen L, Feachem R, Gospodarowicz M, Gralow J, Gupta S, Langer A, Lob-Levyt J, Neal C, Mbewu A, Mired D, Piot P, Reddy KS, Sachs JD, Sarhan M, Seffrin JR.

Lancet. 2010 Oct 2;376(9747):1186-93. doi: 10.1016/S0140-6736(10)61152-X. Epub 2010 Aug 13. Review.


Myths and misconceptions about cervical cancer among Zambian women: rapid assessment by peer educators.

Chirwa S, Mwanahamuntu M, Kapambwe S, Mkumba G, Stringer J, Sahasrabuddhe V, Pfaendler K, Parham G.

Glob Health Promot. 2010 Jun;17(2 Suppl):47-50. doi: 10.1177/1757975910363938.


eC3--a modern telecommunications matrix for cervical cancer prevention in Zambia.

Parham GP, Mwanahamuntu MH, Pfaendler KS, Sahasrabuddhe VV, Myung D, Mkumba G, Kapambwe S, Mwanza B, Chibwesha C, Hicks ML, Stringer JS.

J Low Genit Tract Dis. 2010 Jul;14(3):167-73. doi: 10.1097/LGT.0b013e3181cd6d5e.


Research on cancer prevention, detection and management in low- and medium-income countries.

Sankaranarayanan R, Boffetta P.

Ann Oncol. 2010 Oct;21(10):1935-43. doi: 10.1093/annonc/mdq049. Epub 2010 Mar 15. Review.


Preventing cervical cancer: stakeholder attitudes toward CareHPV-focused screening programs in Roi-et Province, Thailand.

Trope LA, Chumworathayi B, Blumenthal PD.

Int J Gynecol Cancer. 2009 Nov;19(8):1432-8. doi: 10.1111/IGC.0b013e3181a83dd0.


HPV screening for cervical cancer in rural India.

Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, Hingmire S, Malvi SG, Thorat R, Kothari A, Chinoy R, Kelkar R, Kane S, Desai S, Keskar VR, Rajeshwarkar R, Panse N, Dinshaw KA.

N Engl J Med. 2009 Apr 2;360(14):1385-94. doi: 10.1056/NEJMoa0808516.


Implementation of 'see-and-treat' cervical cancer prevention services linked to HIV care in Zambia.

Mwanahamuntu MH, Sahasrabuddhe VV, Pfaendler KS, Mudenda V, Hicks ML, Vermund SH, Stringer JS, Parham GP.

AIDS. 2009 Mar 27;23(6):N1-5. doi: 10.1097/QAD.0b013e3283236e11. No abstract available.


US health aid beyond PEPFAR: the Mother & Child Campaign.

Denny CC, Emanuel EJ.

JAMA. 2008 Nov 5;300(17):2048-51. doi: 10.1001/jama.2008.556. No abstract available.


A new HPV-DNA test for cervical-cancer screening in developing regions: a cross-sectional study of clinical accuracy in rural China.

Qiao YL, Sellors JW, Eder PS, Bao YP, Lim JM, Zhao FH, Weigl B, Zhang WH, Peck RB, Li L, Chen F, Pan QJ, Lorincz AT.

Lancet Oncol. 2008 Oct;9(10):929-36. doi: 10.1016/S1470-2045(08)70210-9. Epub 2008 Sep 19.


Coverage of cervical cancer screening in 57 countries: low average levels and large inequalities.

Gakidou E, Nordhagen S, Obermeyer Z.

PLoS Med. 2008 Jun 17;5(6):e132. doi: 10.1371/journal.pmed.0050132. No abstract available.


Management of cryotherapy-ineligible women in a "screen-and-treat" cervical cancer prevention program targeting HIV-infected women in Zambia: lessons from the field.

Pfaendler KS, Mwanahamuntu MH, Sahasrabuddhe VV, Mudenda V, Stringer JS, Parham GP.

Gynecol Oncol. 2008 Sep;110(3):402-7. doi: 10.1016/j.ygyno.2008.04.031. Epub 2008 Jun 16.


Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial.

Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, Shanthakumari S, Fayette JM, Cherian J.

Lancet. 2007 Aug 4;370(9585):398-406.


Prevalence and distribution of HPV genotypes among HIV-infected women in Zambia.

Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, Stringer JS, Parham GP.

Br J Cancer. 2007 May 7;96(9):1480-3. Epub 2007 Apr 17.


Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana.

Blumenthal PD, Gaffikin L, Deganus S, Lewis R, Emerson M, Adadevoh S; Ghana Cervicare Group.

Am J Obstet Gynecol. 2007 Apr;196(4):407.e1-8; discussion 407.e8-9.


Rapid scale-up of antiretroviral therapy at primary care sites in Zambia: feasibility and early outcomes.

Stringer JS, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, Mtonga V, Reid S, Cantrell RA, Bulterys M, Saag MS, Marlink RG, Mwinga A, Ellerbrock TV, Sinkala M.

JAMA. 2006 Aug 16;296(7):782-93.


Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia.

Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, Vermund SH.

Gynecol Oncol. 2006 Dec;103(3):1017-22. Epub 2006 Jul 27.


Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: a demonstration project.

Gaffikin L, Blumenthal PD, Emerson M, Limpaphayom K; Royal Thai College of Obstetricians and Gynaecologists (RTCOG)/JHPIEGO Corporation Cervical Cancer Prevention Group [corrected].

Lancet. 2003 Mar 8;361(9360):814-20. Erratum in: Lancet. 2003 Jun 7;361(9373):1994.


Supplemental Content

Support Center